Japan's Otsuka to Acquire U.S. Firm Astex for $886M
Sept. 5, 2013
Japanese drugmaker Otsuka Holdings Co. has agreed to buy Astex Pharmaceuticals Inc. for about $886 million to tap cancer drugs under development by the U.S. biotechnology company. Read the full story
